Prognostic phenotypic classification for canine mammary tumors
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
DOI: | 10.3892/ol.2019.11052 |
Texto Completo: | http://dx.doi.org/10.3892/ol.2019.11052 http://hdl.handle.net/11449/197321 |
Resumo: | Mammary neoplasms are a heterogeneous form of disease, and in order to determine its course and biological features with more accuracy, investigations based on tumor phenotypes are required. The aim of the present study was to propose and validate a phenotypic classification for canine mammary tumors and to assess any association between clinicopathological characteristics, survival and prognosis. For the immunohistochemistry analysis, the primary antibodies against estrogen receptor-alpha, progesterone receptor, human epidermal growth factor receptor 2 (HER-2)/neu and E-cadherin were used. A total of 110 canine mammary tumors were investigated; 42 tumors were classified as luminal A, 41 as luminal B, 17 as triple-negative and 10 as HER-2-positive. The luminal A and B phenotypes were associated with improved prognosis, whereas HER-2positive and triple-negative tumors were more aggressive, and exhibited a significant association with the occurrence of metastasis, a worse Tumor-Node-Metastasis classification and shorter survival time (P<0.05). In addition, there were different levels of E-cadherin expression intensity observed among the four tumor profiles investigated. Luminal A and B phenotypes presented an upregulation of E-cadherin compared with the HER-2 positive and triple-negative phenotypes (P<0.05). From the results of the present study, the proposed immunohistochemical panel and phenotypic classification techniques could be useful diagnostic tools with a good technical applicability in veterinary oncology. The analysis of E-cadherin expression in the panel of tumor markers allowed a more accurate classification for determining the biological features of the mammary tumor. |
id |
UNSP_1d49f4c157cb419b42cc040cd05a99e8 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/197321 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Prognostic phenotypic classification for canine mammary tumorsdogsE-cadherinmammary tumorsphenotypesprognosticMammary neoplasms are a heterogeneous form of disease, and in order to determine its course and biological features with more accuracy, investigations based on tumor phenotypes are required. The aim of the present study was to propose and validate a phenotypic classification for canine mammary tumors and to assess any association between clinicopathological characteristics, survival and prognosis. For the immunohistochemistry analysis, the primary antibodies against estrogen receptor-alpha, progesterone receptor, human epidermal growth factor receptor 2 (HER-2)/neu and E-cadherin were used. A total of 110 canine mammary tumors were investigated; 42 tumors were classified as luminal A, 41 as luminal B, 17 as triple-negative and 10 as HER-2-positive. The luminal A and B phenotypes were associated with improved prognosis, whereas HER-2positive and triple-negative tumors were more aggressive, and exhibited a significant association with the occurrence of metastasis, a worse Tumor-Node-Metastasis classification and shorter survival time (P<0.05). In addition, there were different levels of E-cadherin expression intensity observed among the four tumor profiles investigated. Luminal A and B phenotypes presented an upregulation of E-cadherin compared with the HER-2 positive and triple-negative phenotypes (P<0.05). From the results of the present study, the proposed immunohistochemical panel and phenotypic classification techniques could be useful diagnostic tools with a good technical applicability in veterinary oncology. The analysis of E-cadherin expression in the panel of tumor markers allowed a more accurate classification for determining the biological features of the mammary tumor.Conselho Nacional Cientifico e TecnologicoFundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio PretoUniv Estadual Paulista, Fac Agr & Vet Sci, BR-14884900 Jaboticabal, SP, BrazilUniv Estadual Paulista, Ins Biosci Letters & Exact Sci, BR-15054000 Sao Jose Do Rio Preto, SP, BrazilFac Med Sao Jose Do Rio Preto, Dept Mol Biol, Lab Mol Invest Canc, 5418 Brigadeiro Faria Lima Ave, BR-15090000 Sao Jose Do Rio Preto, SP, BrazilAC Camargo Canc Ctr, Int Res Ctr, BR-01508010 Sao Paulo, SP, BrazilUniv Estadual Paulista, Fac Agr & Vet Sci, BR-14884900 Jaboticabal, SP, BrazilUniv Estadual Paulista, Ins Biosci Letters & Exact Sci, BR-15054000 Sao Jose Do Rio Preto, SP, BrazilConselho Nacional Cientifico e Tecnologico: 140624/2013Fundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio Preto: 208/2014Spandidos Publ LtdUniversidade Estadual Paulista (Unesp)Fac Med Sao Jose Do Rio PretoAC Camargo Canc CtrVarallo, Giovanna Rossi [UNESP]Gelaleti, Gabriela Bottaro [UNESP]Maschio-Signorini, Larissa Bazela [UNESP]Moschetta, Marina GobbeLopes, Juliana Ramos [UNESP]De Nardi, Andrigo Barboza [UNESP]Tinucci-Costa, Mirela [UNESP]Rocha, Rafael MalagoliPires De Campos Zuccari, Debora Aparecida2020-12-10T20:13:22Z2020-12-10T20:13:22Z2019-12-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article6545-6553http://dx.doi.org/10.3892/ol.2019.11052Oncology Letters. Athens: Spandidos Publ Ltd, v. 18, n. 6, p. 6545-6553, 2019.1792-1074http://hdl.handle.net/11449/19732110.3892/ol.2019.11052WOS:000505576300100Web of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengOncology Lettersinfo:eu-repo/semantics/openAccess2021-10-23T12:39:36Zoai:repositorio.unesp.br:11449/197321Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T17:21:08.744818Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Prognostic phenotypic classification for canine mammary tumors |
title |
Prognostic phenotypic classification for canine mammary tumors |
spellingShingle |
Prognostic phenotypic classification for canine mammary tumors Prognostic phenotypic classification for canine mammary tumors Varallo, Giovanna Rossi [UNESP] dogs E-cadherin mammary tumors phenotypes prognostic Varallo, Giovanna Rossi [UNESP] dogs E-cadherin mammary tumors phenotypes prognostic |
title_short |
Prognostic phenotypic classification for canine mammary tumors |
title_full |
Prognostic phenotypic classification for canine mammary tumors |
title_fullStr |
Prognostic phenotypic classification for canine mammary tumors Prognostic phenotypic classification for canine mammary tumors |
title_full_unstemmed |
Prognostic phenotypic classification for canine mammary tumors Prognostic phenotypic classification for canine mammary tumors |
title_sort |
Prognostic phenotypic classification for canine mammary tumors |
author |
Varallo, Giovanna Rossi [UNESP] |
author_facet |
Varallo, Giovanna Rossi [UNESP] Varallo, Giovanna Rossi [UNESP] Gelaleti, Gabriela Bottaro [UNESP] Maschio-Signorini, Larissa Bazela [UNESP] Moschetta, Marina Gobbe Lopes, Juliana Ramos [UNESP] De Nardi, Andrigo Barboza [UNESP] Tinucci-Costa, Mirela [UNESP] Rocha, Rafael Malagoli Pires De Campos Zuccari, Debora Aparecida Gelaleti, Gabriela Bottaro [UNESP] Maschio-Signorini, Larissa Bazela [UNESP] Moschetta, Marina Gobbe Lopes, Juliana Ramos [UNESP] De Nardi, Andrigo Barboza [UNESP] Tinucci-Costa, Mirela [UNESP] Rocha, Rafael Malagoli Pires De Campos Zuccari, Debora Aparecida |
author_role |
author |
author2 |
Gelaleti, Gabriela Bottaro [UNESP] Maschio-Signorini, Larissa Bazela [UNESP] Moschetta, Marina Gobbe Lopes, Juliana Ramos [UNESP] De Nardi, Andrigo Barboza [UNESP] Tinucci-Costa, Mirela [UNESP] Rocha, Rafael Malagoli Pires De Campos Zuccari, Debora Aparecida |
author2_role |
author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (Unesp) Fac Med Sao Jose Do Rio Preto AC Camargo Canc Ctr |
dc.contributor.author.fl_str_mv |
Varallo, Giovanna Rossi [UNESP] Gelaleti, Gabriela Bottaro [UNESP] Maschio-Signorini, Larissa Bazela [UNESP] Moschetta, Marina Gobbe Lopes, Juliana Ramos [UNESP] De Nardi, Andrigo Barboza [UNESP] Tinucci-Costa, Mirela [UNESP] Rocha, Rafael Malagoli Pires De Campos Zuccari, Debora Aparecida |
dc.subject.por.fl_str_mv |
dogs E-cadherin mammary tumors phenotypes prognostic |
topic |
dogs E-cadherin mammary tumors phenotypes prognostic |
description |
Mammary neoplasms are a heterogeneous form of disease, and in order to determine its course and biological features with more accuracy, investigations based on tumor phenotypes are required. The aim of the present study was to propose and validate a phenotypic classification for canine mammary tumors and to assess any association between clinicopathological characteristics, survival and prognosis. For the immunohistochemistry analysis, the primary antibodies against estrogen receptor-alpha, progesterone receptor, human epidermal growth factor receptor 2 (HER-2)/neu and E-cadherin were used. A total of 110 canine mammary tumors were investigated; 42 tumors were classified as luminal A, 41 as luminal B, 17 as triple-negative and 10 as HER-2-positive. The luminal A and B phenotypes were associated with improved prognosis, whereas HER-2positive and triple-negative tumors were more aggressive, and exhibited a significant association with the occurrence of metastasis, a worse Tumor-Node-Metastasis classification and shorter survival time (P<0.05). In addition, there were different levels of E-cadherin expression intensity observed among the four tumor profiles investigated. Luminal A and B phenotypes presented an upregulation of E-cadherin compared with the HER-2 positive and triple-negative phenotypes (P<0.05). From the results of the present study, the proposed immunohistochemical panel and phenotypic classification techniques could be useful diagnostic tools with a good technical applicability in veterinary oncology. The analysis of E-cadherin expression in the panel of tumor markers allowed a more accurate classification for determining the biological features of the mammary tumor. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-12-01 2020-12-10T20:13:22Z 2020-12-10T20:13:22Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.3892/ol.2019.11052 Oncology Letters. Athens: Spandidos Publ Ltd, v. 18, n. 6, p. 6545-6553, 2019. 1792-1074 http://hdl.handle.net/11449/197321 10.3892/ol.2019.11052 WOS:000505576300100 |
url |
http://dx.doi.org/10.3892/ol.2019.11052 http://hdl.handle.net/11449/197321 |
identifier_str_mv |
Oncology Letters. Athens: Spandidos Publ Ltd, v. 18, n. 6, p. 6545-6553, 2019. 1792-1074 10.3892/ol.2019.11052 WOS:000505576300100 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Oncology Letters |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
6545-6553 |
dc.publisher.none.fl_str_mv |
Spandidos Publ Ltd |
publisher.none.fl_str_mv |
Spandidos Publ Ltd |
dc.source.none.fl_str_mv |
Web of Science reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1822182410574364672 |
dc.identifier.doi.none.fl_str_mv |
10.3892/ol.2019.11052 |